Perrigo rejects $205/share bid from Mylan
April 21, 2015 at 16:26 PM EDT
April 21 (Reuters) - Dublin-based Perrigo Company Plc said its board unanimously rejected a $205 per share offer from generic drugmaker Mylan NV, saying the bid substantially undervalued the company.